在开发A类GPCR偏差联体的进展
Paula Morales1, Magdalena M Scharf2, Marcel Bermudez3
1Instituto de Química Médica, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
British journal of pharmacology
|September 11, 2024
概括
在G蛋白合受体 (GPCRs) 中偏差信号提供了新的治疗潜力. 功能选择性连接体向特定的途径,为未开发的GPCR寻找更安全,更有效的药物.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 类A G蛋白结合受体 (GPCRs) 对于细胞信号传递至关重要,是重要的药物标.
- 尽管存在药物,超过60%的GPCRs仍然未被利用,因为无偏调节器的局限性.
- 目前GPCR调制剂的不良影响需要新的治疗策略.
研究的目的:
- 审查当前偏向GPCR调节器的药物发现格局.
- 突出了对A类GPCR的功能选择性配体的近期进展.
- 分析这些调节器的治疗相关性,分子基础和临床应用.
主要方法:
- 关于GPCR偏差信号的近期出版物的文献综述.
- 针对个别A类GPCR家族的功能选择性调制剂的编译和分析.
- 剖析治疗相关性,分子决定因素和临床潜力.
主要成果:
- 偏差信号为开发更安全的治疗方法提供了新的途径,通过准特定的受体构造来开发更安全的治疗方法.
- 功能选择性带优先激活不同的信号通路,提高治疗特异性.
- 对偏差信号的理解在不同的A类GPCR家族中有所不同,目前正在研究它们的特定影响.
结论:
- 偏差GPCR调节器在药物发现方面是一个有前途的前沿,提供了更好的安全性和有效性.
- 针对特定的受体-效应因子相互作用可以克服传统GPCR药物的局限性.
- 对单个GPCR家族的进一步研究对于实现偏向信号的全部临床潜力至关重要.
相关概念视频
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
GPCR Desensitization
5.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
G Protein-coupled Receptors
11.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.5K
G-protein Coupled Receptors
117.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
117.1K
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K


